Placing the speed, accuracy, and precision of mass spectrometry in the hands of healthcare providers.
Like much of modern medicine, molecular diagnostics still rely on archaic systems to pinpoint and sufficiently remove suspicious tissue.
It’s a difficult crossroad for providers, patients, and hospitals. Removing too much tissue could impair quality of life, but overlooking even the smallest cluster of cells could mean tumor recurrence and costly adjuvant treatments.
With the MasSpec Pen System™, the best decision is clear.
Tissue is biopsied, sent to the laboratory, frozen, sliced, stained, and examined by a pathologist under a microscope. This process takes 40 minutes, on average. During this wait time, the patient remains under anesthesia, putting them at greater risk of infection and costing both the patient and hospital money.
With the MasSpec Pen System™, a user simply applies three seconds of gentle pressure with the pen-like device. In under 10 seconds, the provider receives a reading of either “cancerous” or “normal” — all without a lab or unnecessary risk for the patient, provider, or hospital.
A complex combination of three technologies powers this simple, scalable diagnostics platform.
User-friendly, disposable, and biocompatible, the simple device connects medical professionals to sophisticated tech previously reserved for experts.
The non-invasive pen-like device enables painless tissue analysis, both in vivo and ex vivo.
3 PATENTS ISSUED
42 PATENTS PENDING
Designed by MS Pen Technologies, the transportable, battery-operated machine can be moved wherever it is most needed — whether that be a patient room or inches from the operating table.
Advanced data analytics and artificial intelligence convert complex metabolic data into simple, actionable information.
Because the process is quick and non-invasive, it can be repeated as many times as necessary if suspicious tissue is still present.
In fact, in the time it took to read about how it works, the MasSpec Pen System™ could have collected and characterized tissue at least once.
Texas Health Catalyst
If you are interested in learning more about MS Pen Technologies, our diagnostic platform, or investment and partnership opportunities, please feel free to reach out.